Postdoctoral Fellowship in Genomic Science and Health Equity
NIH National Human Genome Research Institute & FDA Office of Minority Health and Health Equity
Location: Bethesda, Maryland
Type: Full Time
Preferred Education: Doctorate
Years of Experience:
Less than 2
Salary is determined by experience and years since most recent terminal degree. Salary follows postdoctoral pay ranges determined annually by the U.S. Department of Health and Human Services.
A postdoctoral fellowship in genomic science and health equity, cosponsored by the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI) and the Food and Drug Administration (FDA), Office of Minority Health and Health Equity (OMHHE), is currently open for applications. The interagency Genomic Science and Health Equity Fellowship Program will fund this postdoctoral fellowship. The Fellowship Program prepares fellows to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity and trains them in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics, and devices from the bench to the bedside. Fellows are required to pursue genomics related research that integrates health equity and addresses delivery of new technology in clinical spaces.
Applicants must meet the following requirements:
Have or obtain a Ph.D., M.D., Pharm.D. or D.V.M. in medicine, human genetics, genomics, computational biology, cell or molecular biology, epidemiology, biostatistics, public health, social and behavioral science, or closely related areas.
Have fewer than five years of relevant research experience since receipt most recent doctoral degree.
Have strong laboratory skills, some knowledge of statistics, excellent communication skills and fluency in both spoken and written English.
Be a U.S. citizen or a permanent resident.
Applications will be accepted starting October 11, 2021 and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2022.
Interested candidates should submit the following to Jamil B. Scott, Ph.D., M.PH.
Brief statement of research interests
Names and contact information for two professional references
This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs.
For questions and further information please contact: Jamil B. Scott, Ph.D., M.P.H. | NHGRIFDAFellowship@nih.gov | genome.gov/NHGRIFDA-fellowship
About NIH National Human Genome Research Institute & FDA Office of Minority Health and Health Equity
The National Human Genome Research Institute (NHGRI) was established originally as the National Center for Human Genome Research in 1989 to lead the International Human Genome Project. NHGRI is part of the National Institutes of Health (NIH), the nation’s medical research agency. NHGRI funds and conducts research to uncover the role that the genome plays in human health and disease. This research occurs across a spectrum: basic research to shed light on the structure and function of the genome; translational research to decipher the molecular bases of human diseases; and clinical research to establish how to use genomic information to advance medical care. NHGRI also supports exploration of the complex ethical, legal, and social implications of genomics, and is committed to ensuring that the knowledge and benefits generated from genomics research are disseminated widely, both to fuel current and future researchers and to benefit the general public and promote genomic literacy.
The Food and Drug Administration (FDA) is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping ...the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. The FDA Office of Minority Health and Health Equity (OMHHE) serves to promote and protect the health of diverse populations through research and communication of science that addresses health disparities. The FDA OMHHE aims to: (1) increase the amount of clinical trial data available on racial and ethnic minorities; improve the data quality to determine how minorities react to medical products; and increase transparency and access to available data; (2) strengthen FDA’s ability to respond to minority health concerns and (3) promote health and safety communication to minority populations who often experience low health literacy and/or speak English as a second language.